Related Experiment Video

Updated: Apr 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Regulatory considerations for clinical development of cancer vaccines

Bridget Theresa Heelan1

  • 1a VP (Tech) ; PAREXEL International ; The Quays , UK.

Human Vaccines & Immunotherapeutics
|January 28, 2015
PubMed

Insights

Cancer vaccines stimulate immune responses against tumors. Recent approvals and numerous trials highlight this field

Area of Science:

  • Oncology
  • Immunology
  • Regulatory Science

Background:

  • Cancer vaccines aim to induce immune responses against tumor cells.
  • The field is active with over 1,400 clinical trials registered.
  • Sipuleucel-T's approval marks a milestone, encouraging further development.

Purpose of the Study:

  • To outline current regulatory considerations for cancer vaccine development.
  • To emphasize the need for clear communication with regulatory bodies.
  • To guide developers in navigating the evolving regulatory landscape.

Main Methods:

  • Review of existing regulatory guidelines for cancer vaccines.
  • Analysis of the impact of recent approvals on development strategies.
  • Case-by-case regulatory engagement is recommended.

Main Results:

  • Regulatory guidelines for cancer vaccines are relatively new compared to traditional therapies.
  • Innovative strategies and novel products necessitate tailored regulatory discussions.
  • A clear, evidence-based rationale is crucial for successful regulatory interactions.

Conclusions:

  • Developers should engage in a two-way dialogue with regulators.
  • Justification of clinical development plans must address product-specific quality issues.
  • Successful collaboration ensures alignment between developers and regulatory authorities.
Keywords:
AIDS, Acquired Immunodeficiency SyndromeCAR, T-cell Chimeric Antigen Receptor T-cellCTL-4, Cytotoxic T-lymphocyte-associated protein 4DCs, Dendritic cellsEBV, Ebstein Barr VirusEMA, European Medicines AgencyEU, European UnionFDA, Federal Drug AdministrationHHV-8, Human Herpes Virus 8HTA, Health Technology AssessmentICH, International Conference on HarmonisationICI, Immune Checkpoint InhibitorsITF, Innovation Task ForceMDSC, Myeloid-derived suppressor cellsMHRA, Medicines and Healthcare products Regulatory AgencyMUC1, Membrane-bound glycoprotein MUC1 mucinNICE, National Institute for Heath and Care excellenceOS, Overall survivalPD, PharmacodynamicPD-1, Programmed cell death 1PFS, Progression-free survivalPMDA, Pharmaceutical and Medical Devices AgencyPTLD, Post-transplant lymphoproliferative diseaseRECIST, Response Evaluation Criteria in Solid TumorsSerum Igs, Serum immunoglobulinsT cellsTAA, Tumor associated antigensTIMs, Tumor Infiltrating Myeloid CellTregs, Regulatory T cellsUS, United States of Americaantigenscancer vaccinesimmune systemimmunesurveillancesiRNA, Small interfering RNA

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.7K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.6K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
580
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K